Back to search

Article

Comprehensive circRNA Expression Profile and Transcriptomics-Based Molecular Pathway Analysis of the Sodium-Glucose Co-Transporter-2 Inhibitor Dapagliflozin in Diabetic Tubular Epithelial Cells

2021-08-03

Abstract excerpt

Diabetic kidney disease (DKD) is a serious diabetes complication. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are novel anti-diabetes drugs and have clinical renal protection. However, the molecular mechanisms involved remain unclear. Here, human proximal tubular epithelial cells (PTECs) were treated with normal glucose (NG), high glucose (HG), and three types of anti-diabetes agents including SGLT2i (dapag...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a58a1ef6-bf71-5ce1-ac6e-3a83bbd8403e
DOI
10.21203/rs.3.rs-763466/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comprehensive circRNA Expression Profile and Transcriptomics-Based Molecular Pathway Analysis of the Sodium-Glucose Co-Transporter-2 Inhibitor Dapagliflozin in Diabetic Tubular Epithelial CellsDOI 10.21203/rs.3.rs-763466/v1
Select a neighboring publication to make it the new centre.